Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 06, 2024

BUY
$0.73 - $2.73 $67,799 - $253,551
92,876 New
92,876 $218,000
Q1 2024

May 15, 2024

SELL
$0.73 - $2.73 $80,873 - $302,443
-110,785 Reduced 54.4%
92,876 $218,000
Q4 2023

Feb 14, 2024

BUY
$0.38 - $0.91 $72,172 - $172,834
189,928 Added 1383.0%
203,661 $181,000
Q3 2023

Nov 14, 2023

SELL
$0.79 - $2.83 $17,620 - $63,123
-22,305 Reduced 61.89%
13,733 $11,000
Q2 2023

Aug 14, 2023

BUY
$2.49 - $20.59 $6,229 - $51,516
2,502 Added 7.46%
36,038 $97,000
Q1 2023

May 15, 2023

SELL
$15.95 - $25.18 $4,099 - $6,471
-257 Reduced 0.76%
33,536 $625,000
Q1 2022

May 16, 2022

SELL
$12.02 - $16.79 $2,031 - $2,837
-169 Reduced 0.5%
33,793 $406,000
Q4 2021

Feb 14, 2022

SELL
$9.93 - $15.39 $8,639 - $13,389
-870 Reduced 2.5%
33,962 $478,000
Q3 2021

Nov 15, 2021

BUY
$10.18 - $26.64 $753 - $1,971
74 Added 0.21%
34,832 $356,000
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $45,032 - $86,524
-2,425 Reduced 6.52%
34,758 $926,000
Q1 2021

May 17, 2021

SELL
$31.0 - $55.72 $9.2 Million - $16.5 Million
-296,708 Reduced 88.86%
37,183 $1.29 Million
Q4 2020

Feb 16, 2021

BUY
$37.09 - $48.97 $1.3 Million - $1.72 Million
35,068 Added 11.74%
333,891 $12.4 Million
Q3 2020

Nov 16, 2020

SELL
$40.47 - $45.5 $622,752 - $700,154
-15,388 Reduced 4.9%
298,823 $12.3 Million
Q2 2020

Aug 14, 2020

SELL
$32.57 - $42.83 $1.59 Million - $2.09 Million
-48,876 Reduced 13.46%
314,211 $12.7 Million
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $501,718 - $989,656
-21,533 Reduced 5.6%
363,087 $12.6 Million
Q4 2019

Feb 14, 2020

SELL
$34.58 - $48.06 $6.59 Million - $9.16 Million
-190,518 Reduced 33.13%
384,620 $16.5 Million
Q3 2019

Nov 14, 2019

BUY
$36.98 - $48.45 $1.08 Million - $1.41 Million
29,150 Added 5.34%
575,138 $21.3 Million
Q2 2019

Aug 14, 2019

BUY
$35.13 - $55.53 $2.3 Million - $3.63 Million
65,359 Added 13.6%
545,988 $24.7 Million
Q1 2019

May 15, 2019

SELL
$42.83 - $59.91 $4.32 Million - $6.05 Million
-100,959 Reduced 17.36%
480,629 $26.1 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $1.19 Million - $1.89 Million
-31,466 Reduced 5.13%
581,588 $26.9 Million
Q3 2018

Nov 14, 2018

SELL
$56.3 - $67.25 $5.94 Million - $7.1 Million
-105,589 Reduced 14.69%
613,054 $37.2 Million
Q2 2018

Aug 14, 2018

BUY
$44.9 - $64.95 $889,783 - $1.29 Million
19,817 Added 2.84%
718,643 $45 Million
Q1 2018

May 15, 2018

BUY
$45.35 - $61.65 $1.28 Million - $1.74 Million
28,235 Added 4.21%
698,826 $32.3 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $2.88 Million - $4.13 Million
68,750 Added 11.42%
670,591 $31.8 Million
Q3 2017

Nov 14, 2017

BUY
$33.4 - $53.9 $20.1 Million - $32.4 Million
601,841
601,841 $32.4 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.